Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Methamphetamine-evoked depression of GABA(B) receptor signaling in GABA neurons of the VTA.

Neuron | 2012

Psychostimulants induce neuroadaptations in excitatory and fast inhibitory transmission in the ventral tegmental area (VTA). Mechanisms underlying drug-evoked synaptic plasticity of slow inhibitory transmission mediated by GABA(B) receptors and G protein-gated inwardly rectifying potassium (GIRK/Kir(3)) channels, however, are poorly understood. Here, we show that 1 day after methamphetamine (METH) or cocaine exposure both synaptically evoked and baclofen-activated GABA(B)R-GIRK currents were significantly depressed in VTA GABA neurons and remained depressed for 7 days. Presynaptic inhibition mediated by GABA(B)Rs on GABA terminals was also weakened. Quantitative immunoelectron microscopy revealed internalization of GABA(B1) and GIRK2, which occurred coincident with dephosphorylation of serine 783 (S783) in GABA(B2), a site implicated in regulating GABA(B)R surface expression. Inhibition of protein phosphatases recovered GABA(B)R-GIRK currents in VTA GABA neurons of METH-injected mice. This psychostimulant-evoked impairment in GABA(B)R signaling removes an intrinsic brake on GABA neuron spiking, which may augment GABA transmission in the mesocorticolimbic system.

Pubmed ID: 22405207 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: NS056359
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS048045
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS081986
  • Agency: NINDS NIH HHS, United States
    Id: NS048045
  • Agency: NINDS NIH HHS, United States
    Id: NS051195
  • Agency: NIDA NIH HHS, United States
    Id: DA019022
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS051195
  • Agency: NINDS NIH HHS, United States
    Id: NS054900
  • Agency: NINDS NIH HHS, United States
    Id: P01 NS054900-05
  • Agency: NINDS NIH HHS, United States
    Id: P01 NS054900
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA019022
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS056359
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA019022-05
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS056359-05
  • Agency: NIDA NIH HHS, United States
    Id: DA025236
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS051195-08
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS048045-06
  • Agency: NIDA NIH HHS, United States
    Id: F31 DA029401

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Tocris Bioscience (tool)

RRID:SCR_003689

An Antibody supplier

View all literature mentions

GABABR2 (antibody)

RRID:AB_10672297

This monoclonal targets GABABR2

View all literature mentions

GABA(B)R1 (antibody)

RRID:AB_10672843

This monoclonal targets GABA(B)R1

View all literature mentions

Anti-GABA-B-R2 Antibody (antibody)

RRID:AB_2278802

This monoclonal targets GABA(B)R2

View all literature mentions